Abstract:Recently, the novel coronavirus (SARS-CoV-2), which has spread from China to the world, was declared a global public health emergency, which causes lethal respiratory infections. Acetylation of several proteins plays essential roles in various biological processes, such as viral infections. We reported that the nucleoproteins of influenza virus and Zaire Ebolavirus were acetylated, suggesting that these modifications contributed to the molecular events involved in viral replication. Similar to influenza virus … Show more
“…Our analysis identified a set of metabolites that were significantly altered in COVID-19 overweight-obese patients when compared to COVID-19 lean patients. Data showed significantly upregulated levels of n6-acetyl-l-lysine ( p < 0.01; Figure 3A ), a metabolite that belongs to a class of organic compounds known as l-alpha-amino acids ( 34 ), and is known for its role in chronic inflammation and viral function induction ( 34 , 35 ). In addition to n6-acetyl-l-lysine, data showed significantly upregulated levels of the protein-bound uremic retention solute p-cresol ( p < 0.05) in COVID-19 overweight-obese patients when compared to COVID-19 lean patients ( Figure 3B ).…”
Section: Resultsmentioning
confidence: 99%
“…Similarly, SARS-CoV and SARS-CoV-2 N proteins are shown to be strongly acetylated by human histone acetyltransferases, forming acetyl-lysine residues. These acetylated lysine residues are mainly localized at the N- terminal and C-terminal functional interacting sites of RNA and the membrane (M)-protein ( 35 ), which was shown to play a role in viral infectivity and antigenicity ( 42 ). Although the bi-directional virus-host and chromatin regulation are not yet fully understood, histone modifications have been proven to affect viral chromatin which possibly influence epigenetic factors that mediate viral survival and function, allowing it to escape the immune system ( 43 ).…”
Despite the growing number of the vaccinated population, COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global health burden. Obesity, a metabolic syndrome affecting one-third of the population, has proven to be a major risk factor for COVID-19 severe complications. Several studies have identified metabolic signatures and disrupted metabolic pathways associated with COVID-19, however there are no reports evaluating the role of obesity in the COVID-19 metabolic regulation. In this study we highlight the involvement of obesity metabolically in affecting SARS-CoV-2 infection and the consequent health complications, mainly cardiovascular disease. We measured one hundred and forty-four (144) metabolites using ultra high-performance liquid chromatography-quadrupole time of flight mass spectrometry (UHPLC-QTOF-MS) to identify metabolic changes in response to SARS-CoV-2 infection, in lean and obese COVID-19 positive (n=82) and COVID-19 negative (n=24) patients. The identified metabolites are found to be mainly correlating with glucose, energy and steroid metabolisms. Further data analysis indicated twelve (12) significantly yet differentially abundant metabolites associated with viral infection and health complications, in COVID-19 obese patients. Two of the detected metabolites, n6-acetyl-l-lysine and p-cresol, are detected only among the COVID-19 cohort, exhibiting significantly higher levels in COVID-19 obese patients when compared to COVID-19 lean patients. These metabolites have important roles in viral entry and could explain the increased susceptibility of obese patients. On the same note, a set of six metabolites associated with antiviral and anti-inflammatory functions displayed significantly lower abundance in COVID-19 obese patients. In conclusion, this report highlights the plasma metabolome of COVID-19 obese patients as a metabolic feature and signature to help improve clinical outcomes. We propose n6-acetyl-l-lysine and p-cresol as potential metabolic markers which warrant further investigations to better understand their involvement in different metabolic pathways in COVID-19.
“…Our analysis identified a set of metabolites that were significantly altered in COVID-19 overweight-obese patients when compared to COVID-19 lean patients. Data showed significantly upregulated levels of n6-acetyl-l-lysine ( p < 0.01; Figure 3A ), a metabolite that belongs to a class of organic compounds known as l-alpha-amino acids ( 34 ), and is known for its role in chronic inflammation and viral function induction ( 34 , 35 ). In addition to n6-acetyl-l-lysine, data showed significantly upregulated levels of the protein-bound uremic retention solute p-cresol ( p < 0.05) in COVID-19 overweight-obese patients when compared to COVID-19 lean patients ( Figure 3B ).…”
Section: Resultsmentioning
confidence: 99%
“…Similarly, SARS-CoV and SARS-CoV-2 N proteins are shown to be strongly acetylated by human histone acetyltransferases, forming acetyl-lysine residues. These acetylated lysine residues are mainly localized at the N- terminal and C-terminal functional interacting sites of RNA and the membrane (M)-protein ( 35 ), which was shown to play a role in viral infectivity and antigenicity ( 42 ). Although the bi-directional virus-host and chromatin regulation are not yet fully understood, histone modifications have been proven to affect viral chromatin which possibly influence epigenetic factors that mediate viral survival and function, allowing it to escape the immune system ( 43 ).…”
Despite the growing number of the vaccinated population, COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global health burden. Obesity, a metabolic syndrome affecting one-third of the population, has proven to be a major risk factor for COVID-19 severe complications. Several studies have identified metabolic signatures and disrupted metabolic pathways associated with COVID-19, however there are no reports evaluating the role of obesity in the COVID-19 metabolic regulation. In this study we highlight the involvement of obesity metabolically in affecting SARS-CoV-2 infection and the consequent health complications, mainly cardiovascular disease. We measured one hundred and forty-four (144) metabolites using ultra high-performance liquid chromatography-quadrupole time of flight mass spectrometry (UHPLC-QTOF-MS) to identify metabolic changes in response to SARS-CoV-2 infection, in lean and obese COVID-19 positive (n=82) and COVID-19 negative (n=24) patients. The identified metabolites are found to be mainly correlating with glucose, energy and steroid metabolisms. Further data analysis indicated twelve (12) significantly yet differentially abundant metabolites associated with viral infection and health complications, in COVID-19 obese patients. Two of the detected metabolites, n6-acetyl-l-lysine and p-cresol, are detected only among the COVID-19 cohort, exhibiting significantly higher levels in COVID-19 obese patients when compared to COVID-19 lean patients. These metabolites have important roles in viral entry and could explain the increased susceptibility of obese patients. On the same note, a set of six metabolites associated with antiviral and anti-inflammatory functions displayed significantly lower abundance in COVID-19 obese patients. In conclusion, this report highlights the plasma metabolome of COVID-19 obese patients as a metabolic feature and signature to help improve clinical outcomes. We propose n6-acetyl-l-lysine and p-cresol as potential metabolic markers which warrant further investigations to better understand their involvement in different metabolic pathways in COVID-19.
“…N protein (55,56), S protein (57-59) and M protein (60) are the most common targets for an antigen assay. A wide number of assays can be covered under the term antigen or antigenic tests and assays like ELISA (61) can be used for the antigen tests and chromatographic and mass spectrometry assays (62)(63)(64)(65) are also suitable for the assay purpose; however, lateral fl ow tests (or lateral fl ow immunochromatographic assay or lateral fl ow immunochromatography) are relevant in the current clinical praxis of COVID-19 diagnosis (66). The lateral fl ow tests are also well suited for the point-of-care conditions.…”
Section: The Common Antigen Tests and Comparison With The Other Methodsmentioning
AIMS: This review is focused on the laboratory diagnoses of the coronavirus disease 2019 (COVID-19) by recognizing the antigen of the causative agent SARS-CoV-2 virus. Various antigen tests are available in this moment and these tests are being further developed in order to reach a better diagnostic value. The issue is reviewed in a complex view. METHODS: In this work, a complex survey of the current literature was made. The relevant and recent papers related to antigen tests of COVID-19 are discussed and cited. Basic specifi cations of the antigen tests and competitive methods were also scrutinized in the current literature. RESULTS: The survey of the current literature (years 2019 -2021) was made and diagnostic methods like lateral fl ow tests (lateral fl ow immunochromatographic assay) and various types of biosensors were specifi ed as tools for COVID-19 diagnosis and their application to be used as a point-of-care test is considered. CONCLUSIONS: Small hand-held assays applicable in the point-of-care conditions for diagnosis of COVID-19 by analysis of SARS-CoV-2 antigen are the means of a growing interest and these means undergo a signifi cant development leading to the improvements of their specifi cations and applicability to the current praxis. Merit of the assays is discussed in this paper (Tab. 3, Fig. 2, Ref. 109).
“…Moreover, several viral proteins represent targets of acetylation, such as the Tat protein of HIV [5], the latency-Abbreviations CBB, Coomassie Brilliant Blue; CBP, CREB-binding protein; GCN5, general control nonderepressible 5; HATs, histone acetyltransferases; LC-MS/MS, liquid chromatography with tandem mass spectrometry; MDCK, Madin-Darby canine kidney; NP, nucleoprotein; PCAF, P300/CBP-associated factor; SEM, standard error of the mean; SWATH, sequential window acquisition of all theoretical fragment ion spectra; TwST, Twin-Strep-tagÒ. associated nuclear antigen of Kaposi's sarcomaassociated herpesvirus [6], the E2 protein of human papillomavirus [7,8], the replicase polyprotein pp1ab of MERS coronavirus [9], capsid proteins of recombinant adeno-associated virus [10], foamy virus transactivator Tas [11], nucleoprotein (NP) and VP40 of Zaire ebolavirus [12], and SARS-CoV and SARS-CoV-2 nucleocapsid proteins [13].…”
Section: Introductionmentioning
confidence: 99%
“…Numerous nonhistone proteins can also serve as targets of acetylation; this phenomenon is widely involved in biological processes, including metabolism, cancer, and memory consolidation [2–4]. Moreover, several viral proteins represent targets of acetylation, such as the Tat protein of HIV [5], the latency‐associated nuclear antigen of Kaposi's sarcoma‐associated herpesvirus [6], the E2 protein of human papillomavirus [7,8], the replicase polyprotein pp1ab of MERS coronavirus [9], capsid proteins of recombinant adeno‐associated virus [10], foamy virus transactivator Tas [11], nucleoprotein (NP) and VP40 of Zaire ebolavirus [12], and SARS‐CoV and SARS‐CoV‐2 nucleocapsid proteins [13].…”
The post-translational acetylation of lysine residues is found in many nonhistone proteins and is involved in a wide range of biological processes. Recently, we showed that the nucleoprotein of the influenza A virus is acetylated by histone acetyltransferases (HATs), a phenomenon that affects viral transcription. Here, we report that the PA subunit of influenza A virus RNA-dependent RNA polymerase is acetylated by the HATs, P300/ CREB-binding protein-associated factor (PCAF), and general control nonderepressible 5 (GCN5), resulting in accelerated endonuclease activity. Specifically, the full-length PA subunit expressed in cultured 293T cells was found to be strongly acetylated. Moreover, the partial recombinant protein of the PA N-terminal region containing the endonuclease domain was also acetylated by PCAF and GCN5 in vitro, which facilitated its endonuclease activity. Mass spectrometry analyses identified K19 as a candidate acetylation target in the PA N-terminal region. Notably, the substitution of the lysine residue at position 19 with glutamine, a mimic of the acetyl-lysine residue, enhanced its endonuclease activity in vitro; this point mutation also accelerated influenza A virus RNA-dependent RNA polymerase activity in the cell. Our findings suggest that PA acetylation is important for the regulation of the endonuclease and RNA polymerase activities of the influenza A virus.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.